Vaccines and Childhood Disease
The Disease That Nearly Disappeared — And What Brought It Back
Measles was declared eliminated from an entire continent in 2000, and then, without any change to the virus itself, it came roaring back.
The Idea
Vaccines work through two distinct mechanisms, and most people are only aware of one. The obvious one is individual protection — a primed immune system that recognises a pathogen before it can take hold. The less intuitive one is herd immunity, the population-level shield that emerges when enough people are immune that a pathogen can no longer find easy passage from host to host. For measles, that threshold sits remarkably high — around 95% of a population needs to be immune to break transmission chains. This is because measles is extraordinarily contagious, with a basic reproduction number (R0) of 12–18, meaning one infected person can, in an unprotected population, infect up to 18 others. What this means in practice is that the benefits of vaccination are profoundly collective. When coverage slips — even by a few percentage points — the herd immunity threshold breaks, and the virus finds the gaps. Children too young to be vaccinated, those with immune conditions who cannot receive live vaccines, and a small percentage for whom vaccines don't fully take are all quietly protected by the choices of the majority. When that majority shrinks, these individuals become exposed to real risk, not theoretical risk. This is the part of vaccination that doesn't get discussed enough: it is not merely a private health decision. It is, structurally, a decision about other people's children.
In the World
In 2019, the United States recorded 1,282 measles cases — the highest count in 27 years, concentrated heavily in communities with low vaccination rates. The largest outbreaks occurred in Orthodox Jewish communities in New York's Rockland County and Brooklyn, where sustained misinformation campaigns had driven vaccination rates well below the herd immunity threshold. Public health officials went door to door. The county briefly declared a state of emergency, barring unvaccinated children from public spaces. What made these outbreaks notable was their mechanism. The virus didn't mutate. No vaccine failure was involved. The measles, mumps, and rubella vaccine remained as effective as it had always been — around 97% effective after two doses. What changed was coverage. A network of hesitancy, amplified through social media and concentrated in tight-knit communities, had quietly eroded the invisible shield that protected even vaccinated people. The children who bore the greatest burden were infants under 12 months — too young to have received their first dose — and immunocompromised children who were medically unable to be vaccinated. These are the children who depend entirely on the rest of us. The 2019 outbreaks ended, eventually, through emergency vaccination drives and the blunt interruption of community spread. But the episode made visible something usually invisible: herd immunity is fragile, and its collapse looks exactly like individual families making what feels like a personal choice.
Why It Matters
Understanding vaccines through the lens of collective immunity rather than individual risk changes how you think about public health disagreements. It reframes the question from 'what is the risk to my child?' — a reasonable thing to think about — to 'what is the risk my child's vaccination status creates or removes for others?' This matters for how we talk about these decisions, too. Moral psychologist Jonathan Haidt's research suggests people respond better to care-based framing than to authority or statistics. If someone is hesitant, the most effective conversation isn't usually about data — it's about the premature infant next door, the grandmother on chemotherapy, the cousin who can't be vaccinated because of a severe allergy. These are the people for whom vaccination decisions are not abstract. For parents navigating a noisy information environment, the clearest signal is this: the scientific consensus on vaccine safety and efficacy is as robust as any in modern medicine. The questions worth asking your paediatrician are about timing, scheduling, and your child's specific health context — not about whether the consensus itself is trustworthy.
A Question to Ponder
How often do you think of health decisions as private choices — and which ones might actually be better understood as decisions you're making on behalf of people you'll never meet?
Get a new one of these every morning.
Start learning with Thinkable